Cargando…

Activation of NF-κB driven inflammatory programs in mesenchymal elements attenuates hematopoiesis in low-risk myelodysplastic syndromes

Activation of NF-κB signaling in mesenchymal cells is common in LR-MDS. Activation of NF-κB in mesenchymal cells leads to transcriptional overexpression of inflammatory factors including negative regulators of hematopoiesis. Activation of NF-κB attenuates HSPC numbers and function ex vivo.

Detalles Bibliográficos
Autores principales: Ping, Zhen, Chen, Si, Hermans, Sjoerd J. F., Kenswil, Keane J. G., Feyen, Jacqueline, van Dijk, Claire, Bindels, Eric M. J., Mylona, Athina M., Adisty, Niken M., Hoogenboezem, Remco M., Sanders, Mathijs A., Cremers, Eline M. P., Lindenbergh-Kortleve, Dicky J., Samsom, Janneke N., van de Loosdrecht, Arjan A., Raaijmakers, Marc H. G. P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365382/
https://www.ncbi.nlm.nih.gov/pubmed/30315231
http://dx.doi.org/10.1038/s41375-018-0267-x
_version_ 1783393402965983232
author Ping, Zhen
Chen, Si
Hermans, Sjoerd J. F.
Kenswil, Keane J. G.
Feyen, Jacqueline
van Dijk, Claire
Bindels, Eric M. J.
Mylona, Athina M.
Adisty, Niken M.
Hoogenboezem, Remco M.
Sanders, Mathijs A.
Cremers, Eline M. P.
Lindenbergh-Kortleve, Dicky J.
Samsom, Janneke N.
van de Loosdrecht, Arjan A.
Raaijmakers, Marc H. G. P.
author_facet Ping, Zhen
Chen, Si
Hermans, Sjoerd J. F.
Kenswil, Keane J. G.
Feyen, Jacqueline
van Dijk, Claire
Bindels, Eric M. J.
Mylona, Athina M.
Adisty, Niken M.
Hoogenboezem, Remco M.
Sanders, Mathijs A.
Cremers, Eline M. P.
Lindenbergh-Kortleve, Dicky J.
Samsom, Janneke N.
van de Loosdrecht, Arjan A.
Raaijmakers, Marc H. G. P.
author_sort Ping, Zhen
collection PubMed
description Activation of NF-κB signaling in mesenchymal cells is common in LR-MDS. Activation of NF-κB in mesenchymal cells leads to transcriptional overexpression of inflammatory factors including negative regulators of hematopoiesis. Activation of NF-κB attenuates HSPC numbers and function ex vivo.
format Online
Article
Text
id pubmed-6365382
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-63653822019-02-08 Activation of NF-κB driven inflammatory programs in mesenchymal elements attenuates hematopoiesis in low-risk myelodysplastic syndromes Ping, Zhen Chen, Si Hermans, Sjoerd J. F. Kenswil, Keane J. G. Feyen, Jacqueline van Dijk, Claire Bindels, Eric M. J. Mylona, Athina M. Adisty, Niken M. Hoogenboezem, Remco M. Sanders, Mathijs A. Cremers, Eline M. P. Lindenbergh-Kortleve, Dicky J. Samsom, Janneke N. van de Loosdrecht, Arjan A. Raaijmakers, Marc H. G. P. Leukemia Brief Communication Activation of NF-κB signaling in mesenchymal cells is common in LR-MDS. Activation of NF-κB in mesenchymal cells leads to transcriptional overexpression of inflammatory factors including negative regulators of hematopoiesis. Activation of NF-κB attenuates HSPC numbers and function ex vivo. Nature Publishing Group UK 2018-10-12 2019 /pmc/articles/PMC6365382/ /pubmed/30315231 http://dx.doi.org/10.1038/s41375-018-0267-x Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Brief Communication
Ping, Zhen
Chen, Si
Hermans, Sjoerd J. F.
Kenswil, Keane J. G.
Feyen, Jacqueline
van Dijk, Claire
Bindels, Eric M. J.
Mylona, Athina M.
Adisty, Niken M.
Hoogenboezem, Remco M.
Sanders, Mathijs A.
Cremers, Eline M. P.
Lindenbergh-Kortleve, Dicky J.
Samsom, Janneke N.
van de Loosdrecht, Arjan A.
Raaijmakers, Marc H. G. P.
Activation of NF-κB driven inflammatory programs in mesenchymal elements attenuates hematopoiesis in low-risk myelodysplastic syndromes
title Activation of NF-κB driven inflammatory programs in mesenchymal elements attenuates hematopoiesis in low-risk myelodysplastic syndromes
title_full Activation of NF-κB driven inflammatory programs in mesenchymal elements attenuates hematopoiesis in low-risk myelodysplastic syndromes
title_fullStr Activation of NF-κB driven inflammatory programs in mesenchymal elements attenuates hematopoiesis in low-risk myelodysplastic syndromes
title_full_unstemmed Activation of NF-κB driven inflammatory programs in mesenchymal elements attenuates hematopoiesis in low-risk myelodysplastic syndromes
title_short Activation of NF-κB driven inflammatory programs in mesenchymal elements attenuates hematopoiesis in low-risk myelodysplastic syndromes
title_sort activation of nf-κb driven inflammatory programs in mesenchymal elements attenuates hematopoiesis in low-risk myelodysplastic syndromes
topic Brief Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365382/
https://www.ncbi.nlm.nih.gov/pubmed/30315231
http://dx.doi.org/10.1038/s41375-018-0267-x
work_keys_str_mv AT pingzhen activationofnfkbdriveninflammatoryprogramsinmesenchymalelementsattenuateshematopoiesisinlowriskmyelodysplasticsyndromes
AT chensi activationofnfkbdriveninflammatoryprogramsinmesenchymalelementsattenuateshematopoiesisinlowriskmyelodysplasticsyndromes
AT hermanssjoerdjf activationofnfkbdriveninflammatoryprogramsinmesenchymalelementsattenuateshematopoiesisinlowriskmyelodysplasticsyndromes
AT kenswilkeanejg activationofnfkbdriveninflammatoryprogramsinmesenchymalelementsattenuateshematopoiesisinlowriskmyelodysplasticsyndromes
AT feyenjacqueline activationofnfkbdriveninflammatoryprogramsinmesenchymalelementsattenuateshematopoiesisinlowriskmyelodysplasticsyndromes
AT vandijkclaire activationofnfkbdriveninflammatoryprogramsinmesenchymalelementsattenuateshematopoiesisinlowriskmyelodysplasticsyndromes
AT bindelsericmj activationofnfkbdriveninflammatoryprogramsinmesenchymalelementsattenuateshematopoiesisinlowriskmyelodysplasticsyndromes
AT mylonaathinam activationofnfkbdriveninflammatoryprogramsinmesenchymalelementsattenuateshematopoiesisinlowriskmyelodysplasticsyndromes
AT adistynikenm activationofnfkbdriveninflammatoryprogramsinmesenchymalelementsattenuateshematopoiesisinlowriskmyelodysplasticsyndromes
AT hoogenboezemremcom activationofnfkbdriveninflammatoryprogramsinmesenchymalelementsattenuateshematopoiesisinlowriskmyelodysplasticsyndromes
AT sandersmathijsa activationofnfkbdriveninflammatoryprogramsinmesenchymalelementsattenuateshematopoiesisinlowriskmyelodysplasticsyndromes
AT cremerselinemp activationofnfkbdriveninflammatoryprogramsinmesenchymalelementsattenuateshematopoiesisinlowriskmyelodysplasticsyndromes
AT lindenberghkortlevedickyj activationofnfkbdriveninflammatoryprogramsinmesenchymalelementsattenuateshematopoiesisinlowriskmyelodysplasticsyndromes
AT samsomjanneken activationofnfkbdriveninflammatoryprogramsinmesenchymalelementsattenuateshematopoiesisinlowriskmyelodysplasticsyndromes
AT vandeloosdrechtarjana activationofnfkbdriveninflammatoryprogramsinmesenchymalelementsattenuateshematopoiesisinlowriskmyelodysplasticsyndromes
AT raaijmakersmarchgp activationofnfkbdriveninflammatoryprogramsinmesenchymalelementsattenuateshematopoiesisinlowriskmyelodysplasticsyndromes